Abstract |
Intraneuronal prion protein (PrP) immunoreactivity (INIR), which might represent the non-pathological, cellular form of PrP, needs to be distinguished from disease-associated deposits specific for prion disease (PrD). In adjacent sections of PrD and control brains we applied pretreatments, one of which enhances the immunoreactivity of disease-associated PrP, and another that enhances INIR. We observed an inverse correlation between the proportion of neurons with INIR and the intensity of disease-associated PrP immunoreactivity and severity of lesions. Additionally, we found large intracytoplasmic inclusion-like bodies in ballooned neurons in PrD cases. We noted that the 3F4 ( epitope: amino acids 109-112) anti-PrP antibody labels more INIR than antibodies directed against amino acids 23-85 (BG4) or 140-180 (KG9) in PrD cases, in contrast to controls, but all antibodies immunolabel more INIR in PrD brains. The up-regulation of PrP might represent an early loss of function of the non-pathological form of PrP, in parallel with a neurotoxic effect of accumulating disease-associated isoform, as part of the pathogenesis of prion diseases.
|
Authors | Gabor G Kovacs, Till Voigtländer, Johannes A Hainfellner, Herbert Budka |
Journal | Acta neuropathologica
(Acta Neuropathol)
Vol. 104
Issue 3
Pg. 320-6
(Sep 2002)
ISSN: 0001-6322 [Print] Germany |
PMID | 12172919
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- PrPC Proteins
- PrPSc Proteins
|
Topics |
- Adult
- Aged
- Brain
(metabolism, pathology)
- Creutzfeldt-Jakob Syndrome
(etiology, metabolism, pathology)
- Humans
- Immunohistochemistry
- Middle Aged
- Neurons
(metabolism)
- PrPC Proteins
(biosynthesis)
- PrPSc Proteins
(biosynthesis)
|